Letter to the Editor.

Autor: Monroy-Jaramillo N; Department of Neurogenetics, Instituto Nacional de Neurología y Neurocirugía 'Manuel Velasco Suárez', Mexico City., Cerón A; Department of Neurology, Instituto Nacional de Neurología y Neurocirugía 'Manuel Velasco Suárez', Mexico City., León E; Department of Neurology, Instituto Nacional de Neurología y Neurocirugía 'Manuel Velasco Suárez', Mexico City., Rivas V; Department of Experimental Laboratory of Neurodegenerative Diseases, Instituto Nacional de Neurología y Neurocirugía 'Manuel Velasco Suárez', Mexico City., Ochoa-Morales A; Department of Neurogenetics, Instituto Nacional de Neurología y Neurocirugía 'Manuel Velasco Suárez', Mexico City., Arteaga-Alcaraz MG; State Research Coordinator, Mexican Social Security Institute, Pachuca, Hgo., Nocedal-Rustrian FC; Regional Hospital #25 'Ignacio Zaragoza', Mexican Social Security Institute, Mexico City., Gallegos C; Department of Pathology, Hospital Ángeles del Pedregal, Mexico City, Mexico., Alonso-Vilatela ME; Department of Neurogenetics, Instituto Nacional de Neurología y Neurocirugía 'Manuel Velasco Suárez', Mexico City., Corona T; Department of Experimental Laboratory of Neurodegenerative Diseases, Instituto Nacional de Neurología y Neurocirugía 'Manuel Velasco Suárez', Mexico City., Flores J; Department of Experimental Laboratory of Neurodegenerative Diseases, Instituto Nacional de Neurología y Neurocirugía 'Manuel Velasco Suárez', Mexico City.

Publikováno v: Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion [Rev Invest Clin] 2019; Vol. 71 (2), pp. 142.

Incremento en el riesgo de neoplasia entre familiares de pacientes con glioma

Autor: Gutiérrez-Castrellón P, González-Aguilar A, Rasmussen A, Alonso-Vilatela Me, Briceño E, Rembao-Bojórquez D

Publikováno v: Revista de Neurología. 47:343

Introduccion. Estudios previos han sugerido que existe agregacion familiar de gliomas; sin embargo, los resultados no siempre han sido replicables. Sujetos y metodos. En el presente estudio de una poblacion mexicana, comparamos 100 casos de glioma co

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f40096b5bad8764d5e034ef3a2ee1caf
https://doi.org/10.33588/rn.4707.2008371

DNA repair pathways underlie a common genetic mechanism modulating onset in polyglutamine diseases.

Autor: Bettencourt C; Department of Molecular Neuroscience, Institute of Neurology, University College London, London WC1N 3BG, United Kingdom.; Department of Clinical and Experimental Epilepsy, Institute of Neurology, University College London, London WC1N 3BG, United Kingdom., Hensman-Moss D; Department of Neurodegenerative Disease, Institute of Neurology, University College London, London WC1N 3BG, United Kingdom., Flower M; Department of Neurodegenerative Disease, Institute of Neurology, University College London, London WC1N 3BG, United Kingdom., Wiethoff S; Department of Molecular Neuroscience, Institute of Neurology, University College London, London WC1N 3BG, United Kingdom.; Center for Neurology and Hertie Institute for Clinical Brain Research, Eberhard-Karls-University, Tübingen, Germany., Brice A; Inserm U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC University Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle épinière (ICM), Paris, France.; APHP, Department of Genetics, University Hospital Pitié-Salpêtrière, 75013 Paris, France., Goizet C; Université Bordeaux, Laboratoire Maladies Rares: Génétique et Métabolisme, INSERM1211, Bordeaux, France.; CHU Pellegrin, Service de Génétique Médicale, F-33000, Bordeaux, France., Stevanin G; Inserm U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC University Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle épinière (ICM), Paris, France.; Ecole Pratique des Hautes Etudes, 75014 Paris, France., Koutsis G; Neurogenetics Unit, 1st Department of Neurology, University of Athens Medical School, Eginition Hospital, 115 28 Athens, Greece., Karadima G; Neurogenetics Unit, 1st Department of Neurology, University of Athens Medical School, Eginition Hospital, 115 28 Athens, Greece., Panas M; Neurogenetics Unit, 1st Department of Neurology, University of Athens Medical School, Eginition Hospital, 115 28 Athens, Greece., Yescas-Gómez P; Neurogenetics Department, National Institute of Neurology and Neurosurgery, 'Manuel Velasco Suárez', Mexico City CP14269, Mexico., García-Velázquez LE; Neurogenetics Department, National Institute of Neurology and Neurosurgery, 'Manuel Velasco Suárez', Mexico City CP14269, Mexico., Alonso-Vilatela ME; Neurogenetics Department, National Institute of Neurology and Neurosurgery, 'Manuel Velasco Suárez', Mexico City CP14269, Mexico., Lima M; Department of Biology, University of the Azores, 9500-321 Ponta Delgada, Portugal.; Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4150-180 Porto, Portugal.; Institute for Molecular and Cell Biology (IBMC), University of Porto, 4150-180 Porto, Portugal., Raposo M; Department of Biology, University of the Azores, 9500-321 Ponta Delgada, Portugal.; Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4150-180 Porto, Portugal.; Institute for Molecular and Cell Biology (IBMC), University of Porto, 4150-180 Porto, Portugal., Traynor B; Laboratory of Neurogenetics, National Institute of Aging, NIH, Bethesda, MD 20892, USA., Sweeney M; Neurogenetics Unit, National Hospital for Neurology and Neurosurgery, University College London Hospitals, London WC1N 3BG, United Kingdom., Wood N; Department of Molecular Neuroscience, Institute of Neurology, University College London, London WC1N 3BG, United Kingdom., Giunti P; Department of Molecular Neuroscience, Institute of Neurology, University College London, London WC1N 3BG, United Kingdom.; Ataxia Center, Institute of Neurology, University College London, London WC1N 3BG, United Kingdom., Durr A; Inserm U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC University Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle épinière (ICM), Paris, France.; APHP, Department of Genetics, University Hospital Pitié-Salpêtrière, 75013 Paris, France., Holmans P; MRC Centre for Neuropsychiatric Genetics and Genomics, Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, CF24 4HQ, United Kingdom., Houlden H; Department of Molecular Neuroscience, Institute of Neurology, University College London, London WC1N 3BG, United Kingdom.; Neurogenetics Unit, National Hospital for Neurology and Neurosurgery, University College London Hospitals, London WC1N 3BG, United Kingdom., Tabrizi SJ; Department of Neurodegenerative Disease, Institute of Neurology, University College London, London WC1N 3BG, United Kingdom., Jones L; MRC Centre for Neuropsychiatric Genetics and Genomics, Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, CF24 4HQ, United Kingdom.

Publikováno v: Annals of neurology [Ann Neurol] 2016 Jun; Vol. 79 (6), pp. 983-90. Date of Electronic Publication: 2016 May 06.

Prionic diseases genetics. (Spanish)

Autor: Yescas-Gómez P, López-López M, Franco JL, Alonso-Vilatela ME

Publikováno v: Archivos de Neurociencias; oct-dic2008, Vol. 13 Issue 4, p242-251, 10p

Genetics of multiple sclerosis. (Spanish)

Autor: Rasmussen-Almaraz A, Alonso-Vilatela ME

Publikováno v: Archivos de Neurociencias; ene99, Vol. 4 Issue 1, p35-38, 4p